首页> 外文期刊>Marine Drugs >An HPLC Method for Microanalysis and Pharmacokinetics of Marine Sulfated Polysaccharide PSS-Loaded Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles in Rat Plasma
【24h】

An HPLC Method for Microanalysis and Pharmacokinetics of Marine Sulfated Polysaccharide PSS-Loaded Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles in Rat Plasma

机译:HPLC法对大鼠血浆中海洋硫酸化多糖PSS负载的聚乳酸-乙醇酸共聚物(PLGA)纳米微粒进行微分析和药代动力学

获取原文
获取外文期刊封面目录资料

摘要

This study was aimed at developing a sensitive and selective HPLC method with postcolumn fluorescence derivatization for the detection of propylene glycol alginate sodium sulfate (PSS) in rat plasma. Plasma samples were prepared by a simple and fast ultrafiltration method. PSS was extracted from rat plasma with d-glucuronic acid as internal standard. Isocratic chromatographic separation was performed on a TSKgel G2500 PWxL column with the mobile phase of 0.1 M sodium sulfate at a flow rate of 0.5 mL/min. Analyte detection was achieved by fluorescence detection (FLD) at 250 nm (excitation) and 435 nm (emission) using guanidine hydrochloride as postcolumn derivatizing reagent in an alkaline medium at 120 °C. The calibration curve was linear over a concentration range of 1–500 μg/mL, and the lower limit of detection (LLOD) was found to be 250 ng/mL. This validated method was applied successfully to the pharmacokinetic study of PSS and PSS-loaded poly lactic-co-glycolic acid (PLGA) nanoparticles (PSS-NP) in rat plasma after a single intravenous (PSS only) and oral administration (PSS and PSS-NP). Significant differences in the main pharmacokinetic parameters of PSS and PSS-NP were observed. The relative bioavailability of PSS-NP was 190.10% compared with PSS which shows that PSS-NP can improve oral bioavailability.
机译:这项研究旨在开发一种灵敏的,选择性的HPLC方法,采用柱后荧光衍生化技术检测大鼠血浆中的藻酸丙二醇硫酸钠(PSS)。通过简单,快速的超滤方法制备血浆样品。以d-葡萄糖醛酸为内标从大鼠血浆中提取PSS。在TSKgel G2500 PWxL色谱柱上进行等度色谱分离,流动相为0.1 M硫酸钠,流速为0.5 mL / min。在120°C的碱性介质中,使用盐酸胍作为柱后衍生试剂,通过在250 nm(激发)和435 nm(发射)的荧光检测(FLD)进行分析物检测。校准曲线在1–500μg/ mL的浓度范围内呈线性,检测下限(LLOD)为250 ng / mL。这种经过验证的方法已成功应用于大鼠血浆中的PSS和PSS负载的聚乳酸-乙醇酸(PLGA)纳米颗粒(PSS-NP)的单次静脉内(仅PSS)和口服给药(PSS和PSS)后的药代动力学研究-NP)。观察到PSS和PSS-NP的主要药代动力学参数存在显着差异。与PSS相比,PSS-NP的相对生物利用度为190.10%,这表明PSS-NP可以提高口服生物利用度。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号